Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
3.220
-0.060 (-1.83%)
Dec 5, 2025, 4:00 PM EST - Market closed
Grace Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Net Income | -7.82 | -9.57 | -12.85 | -42.43 | -9.82 | -19.68 | |
| Depreciation & Amortization | 0.01 | 0.01 | 0.01 | 0.12 | - | 0.92 | |
| Other Amortization | - | - | - | - | - | 0.26 | |
| Loss (Gain) From Sale of Assets | 0 | 0 | -0.02 | - | - | - | |
| Asset Writedown & Restructuring Costs | - | - | - | 33.95 | 0.25 | 5.7 | |
| Stock-Based Compensation | 0.8 | 0.73 | 0.91 | 1.81 | 1.34 | 1.17 | |
| Other Operating Activities | -4.03 | -6.42 | 0.9 | -9.55 | -6.22 | 3.24 | |
| Change in Accounts Receivable | 0.4 | 0.6 | 0.08 | -0.3 | -0.02 | 0.06 | |
| Change in Accounts Payable | -1.43 | -0.08 | -1.65 | 0.41 | -2.39 | -6.7 | |
| Change in Other Net Operating Assets | 0.06 | -0.17 | 0.29 | 0.07 | -0.38 | 0.7 | |
| Operating Cash Flow | -12.01 | -14.9 | -12.33 | -15.91 | -17.23 | -14.32 | |
| Capital Expenditures | - | - | -0.02 | -0.02 | - | -0.07 | |
| Sale of Property, Plant & Equipment | - | - | 0.11 | - | - | - | |
| Investment in Securities | 0.02 | - | 0.02 | 13.17 | -3.52 | -9.79 | |
| Investing Cash Flow | 0.02 | - | 0.1 | 13.15 | -3.52 | -9.86 | |
| Issuance of Common Stock | 15 | 15 | 7.52 | 0.3 | - | 59.63 | |
| Other Financing Activities | -1.29 | -0.97 | -0.16 | - | - | -0.14 | |
| Financing Cash Flow | 13.71 | 14.03 | 7.36 | 0.3 | - | 59.49 | |
| Foreign Exchange Rate Adjustments | - | - | - | -0.01 | 0.15 | 1.39 | |
| Net Cash Flow | 1.71 | -0.87 | -4.87 | -2.46 | -20.6 | 36.7 | |
| Free Cash Flow | -12.01 | -14.9 | -12.36 | -15.93 | -17.23 | -14.39 | |
| Free Cash Flow Margin | - | - | - | - | - | -7340.82% | |
| Free Cash Flow Per Share | -0.84 | -1.23 | -1.30 | -2.14 | -2.81 | -5.82 | |
| Levered Free Cash Flow | -7.98 | -9.01 | -7.4 | -9.06 | -4.57 | -7.81 | |
| Unlevered Free Cash Flow | -7.98 | -9.01 | -7.4 | -9.06 | -4.57 | -7.91 | |
| Change in Working Capital | -0.97 | 0.34 | -1.28 | 0.18 | -2.79 | -5.95 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.